MRSA

Clinical picture

Methicillin-resistant Staphylococcus aureus, or MRSA for short, is a type of staphylococcus. Staphylococci are bacteria that are commonly found in healthy people, without causing them any problems. MRSA is a special type of staphylococcus because it is insensitive (resistant) to treatment with most antibiotics.

The bacteria are mainly found on the skin and in the nose of these 'carriers', but can also occur in the throat, intestines, and urine.

MRSA can cause infections. These are generally skin infections, such as boils. In rare cases, blood poisoning, bone infection, or pneumonia can occur.

Route of transmission

Direct contact via the hands, via the air (skin flakes in the air), surfaces in the immediate vicinity.

Contagious period

As long as someone is a carrier.

Incubation period

Not determinable.

Vaccination and prevention policy

Vaccination: no vaccination is available.

Prevention: screening when starting employmentdepending on your own umc policy. For identified risk groups (see SRI guideline MRSA), take isolation measures; see your own umc policy for this. In the event of unprotected exposure, contact tracing among employees will follow.

Risk of infection

Contagiousness from carriers or infected individuals.

Increased risk of infection/carriage

  • People with compromised immune systems.
  • People with skin conditions.
  • Healthcare workers.

Increased risk of severe progression

  • People with compromised immune systems.
  • Newborns and the elderly.

Risk of further spread

S. aureus strains spread most effectively among people who live in close proximity to each other, such as in healthcare institutions and within families.

Protective measures

See SRI guideline MRSA. Depending on the isolation policy of your umc; gloves, type IIR mouth and nose mask, long-sleeved apron.

Policy after unprotected exposure

Depending on the setting and situation, contact tracing may be carried out among healthcare workers.

Policy for MRSA carriage/infection in healthcare workers

The policy is based on detecting and treating MRSA carriage/infections as quickly as possible. Employees are offered treatment via the company doctor. This is followed by a culture process lasting at least 1 year (see SRI guideline MRSA).

Healthcare workers who are colonized with MRSA (carriers) are initially prohibited from performing patient-related work.

If an employee is a chronic (permanent) MRSA carrier, it is up to the umc to decide whether the employee can continue to work in direct patient care under certain conditions, weighing patient safety against personnel policy. (see SRI guideline MRSA).